Marksans Pharma informs about press release

21 Aug 2024 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksans Pharma Limited’s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products’.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

170.85 0.90 (0.53%)
23-Jan-2026 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1629.00
Dr. Reddys Lab 1245.00
Cipla 1372.50
Zydus Lifesciences 891.25
Lupin 2149.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×